Arterial remodeling and coronary artery disease: the concept of “dilated” versus “obstructive” coronary atherosclerosis  by Schoenhagen, Paul et al.
REVIEW ARTICLES
Arterial Remodeling and Coronary
Artery Disease: The Concept of “Dilated”
Versus “Obstructive” Coronary Atherosclerosis
Paul Schoenhagen, MD, Khaled M. Ziada, MD, D. Geoffrey Vince, PHD, Steven E. Nissen, MD, FACC,
E. Murat Tuzcu, MD, FACC
Cleveland, Ohio
Traditionally, the development of coronary artery disease (CAD) was described as a gradual
growth of plaques within the intima of the vessel. The outer boundaries of the intima, the
media and the external elastic membrane (EEM), were thought to be fixed in size. In this
model plaque growth would always lead to luminal narrowing and the number and severity
of angiographic stenoses would reflect the extent of coronary disease. However, histologic
studies demonstrated that certain plaques do not reduce luminal size, presumably because of
expansion of the media and EEM during atheroma development. This phenomenon of
“arterial remodeling” was confirmed in necropsy specimens of human coronary arteries. More
recently, the development of contemporary imaging technology, particularly intravascular
ultrasound, has allowed the study of arterial remodeling in vivo. These new imaging
modalities have confirmed that plaque progression and regression are not closely related to
luminal size. In this review, we will analyze the role of remodeling in the progression and
regression of native CAD, as well as its impact on restenosis after coronary intervention.
(J Am Coll Cardiol 2001;38:297–306) © 2001 by the American College of Cardiology
In a variety of clinical settings, blood vessels react with
expansion or constriction to physiologic or pathophysiologic
conditions. Examples include the closure of the fetal ductus
arteriosus after birth (1), the formation of collateral vessels
or arteriovenous fistulas and vascular changes associated
with hypertension (2). These compensatory changes of
vessel size and structure are termed vascular remodeling. In
other clinical entities, notably abdominal aortic aneurysms,
the change in vessel size appears to be the disease-initiating
event rather than a compensatory reaction.
On the basis of observations of pressure-distended or
undistended aortic wall specimens, Crawford and Levene
(3) stated in 1953 that “ordinary atheromatous plaques do
not project into the lumen but lie in a depression in the
media, which may bulge outwards.” This arterial expansion
at sites of coronary atherosclerotic lesions was confirmed in
animal models of coronary disease (4,5). Midlimb and
coronary arteries of cynomolgus monkeys were found to
enlarge in response to plaque formation induced by an
atherogenic diet. Importantly, luminal size was initially
unaffected by plaque growth (5). Glagov et al. (6) subse-
quently demonstrated this phenomenon in a necropsy study
of 136 human coronary arteries, showing a significant
positive correlation between internal elastic lamina area and
plaque area. Luminal area was unaffected by plaque growth
until the lesion reached 40% area stenosis; above 40% area
stenosis, luminal area diminished in a close relationship to
the percentage of stenosis (Fig. 1).
In vivo studies of human coronary arteries using intra-
vascular ultrasound (IVUS) imaging found a similar corre-
lation between atheroma and external elastic membrane
(EEM) area (7). Using epicardial ultrasound, Mc Pherson
et al. (8) introduced the examination of arterial remodeling
in individual lesions by comparing EEM area at the lesion
and proximal reference site of the same vessel. Subsequently,
in an IVUS study Ge et al. (9) reported that the EEM area
of atherosclerotic segments was significantly larger than that
of proximal segments. Further histologic and IVUS studies
demonstrated that arterial remodeling could be bidirec-
tional. “Positive remodeling” as observed by Glagov et al. (6)
describes an expansion in EEM area and “negative remod-
eling” describes shrinkage of EEM area at the lesion site
(Fig. 2) (10,11). Mintz et al. (12) used IVUS to examine
603 coronary atherosclerotic lesions in patients presenting
with stable angina. Inadequate or negative remodeling was
defined as a ratio of lesion EEM to proximal reference
EEM area #0.78 and was found in 15% of lesions.
Diagnostic methods. Intravascular ultrasound and mag-
netic resonance imaging (MRI) are the primary clinical
methods to investigate arterial remodeling in vivo. Intravas-
cular ultrasound provides tomographic imaging of the vessel
wall (Fig. 3) (13). During coronary angiography a
transducer-tipped ultrasound catheter is advanced into the
vessel beyond the target lesion site. The catheter is then
withdrawn through the lesion, yielding a series of tomo-
graphic images. Each image is analyzed individually. Plaque
morphology is classified as soft, fibrotic or calcific based on
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echodensity on a continuum from echolucent to echodense.
However, the visual classification of plaque composition is
limited because the categories available from qualitative
evaluation of video images are coarse. Advanced analysis of
the IVUS data with, for example, radiofrequency analysis
may allow a more detailed description.
Intravascular ultrasound provides excellent boundary def-
inition for tissue interfaces with an abrupt change in
acoustic impedance. Although the media can not always be
separated from the intima, the blood-intima border and the
EEM are easily identified and allow the measurement of
luminal area, intima-media area and EEM area (14).
Therefore, with IVUS, the extent and direction of arterial
remodeling can be derived from measurements of the EEM
area at the target lesion site and a reference site. At each site,
the EEM area is measured at the leading edge of the
adventitia. The remodeling ratio is defined as the ratio of
the EEM area at the lesion site to the EEM area at the
proximal reference site (Fig. 2). Although the remodeling
response is a continuous variable, its direction is often
classified categorically. A frequently used definition differ-
entiates positive remodeling, absence of remodeling and
negative remodeling, defined as a remodeling ratio .1.05,
0.95 to 1.05 and ,0.95 respectively (Figs. 2, 4 and 5) (15).
Magnetic resonance imaging is a noninvasive three-
dimensional imaging technique that differentiates tissue
structures on the basis of their proton magnetic properties.
In recent human and serial animal studies MRI has been
shown to accurately quantify the vessel wall area, allowing
assessment of arterial remodeling (16,17). Significant tech-
nical improvements in resolution and gating are needed
before this technique can be applied to the examination of
coronary arteries in clinical settings (18).
Definitions of remodeling. Many methodologic problems
remain regarding the optimal approach to define arterial
remodeling. Theoretically, arterial remodeling describes dy-
namic changes of the EEM area over time. However,
clinical studies of remodeling often examine this phenom-
enon at a single, static point in time. In most histologic
investigations and some IVUS studies, the existence of
remodeling is inferred from the comparison of plaque and
EEM size in groups of lesions of differing severity (6,7).
Positive remodeling is defined by a positive correlation
between plaque and EEM area. In this type of analysis, the
extent and direction of remodeling can be described for a
large group of lesions, but not for specific sites.
To assess the extent and direction of remodeling in
individual lesions, it is necessary to compare vessel size at
the lesion site to an adjacent reference site that contains
Abbreviations and Acronyms
CAD 5 coronary artery disease
EEM 5 external elastic membrane
IVUS 5 intravascular ultrasound
MRI 5 magnetic resonance imaging
SVG 5 saphenous vein grafts
TLR 5 target lesion revascularization rate
Figure 1. Early plaque accumulation in human coronary arteries is associated with compensatory enlargement of vessel size (positive remodeling). Therefore,
luminal size is initially not affected by plaque growth. These complex changes of lumen, plaque and external elastic membrane (EEM) may also affect plaque
regression. Adapted from Glagov et al. (6). CAD 5 coronary artery disease.
298 Schoenhagen et al. JACC Vol. 38, No. 2, 2001
Remodeling and Coronary Artery Disease August 2001:297–306
minimal disease (Fig. 6) (8,19). Assuming that the original
vessel size was similar at the lesion and reference site, this
definition describes the extent of arterial expansion or
shrinkage at the lesion site. Positive and negative remodel-
ing is defined as larger or smaller EEM area at the lesion site
than at an adjacent reference site (Fig. 2). However, the
comparison of EEM size at the lesion and reference site has
several limitations. Theoretically, the “normal” EEM area at
any lesion should be smaller than the EEM area at a
proximal reference site and larger than the EEM area at a
distal reference site, because of vessel tapering. Therefore,
the EEM area at the lesion site is influenced by its distance
from the reference site. Furthermore, angiographically “nor-
mal” reference segments frequently contain mild to moder-
ate atherosclerosis, and a truly normal segment from which
to calculate the “normal” EEM area may not exist (20).
In contrast to describing the static extent of remodeling,
serial observations of lesion sites can define the dynamic
process of remodeling (Fig. 7). It is crucial to differentiate
between dynamic and static observations, because both can
coexist. For example, in a longitudinal designed pharmaco-
logic intervention trial, a positive remodeled lesion (defined
by the comparison of lesion and reference site before
treatment) could subsequently undergo negative remodeling
(defined by comparison of the lesion site before and after
treatment) as a consequence of the drug effect.
Pathophysiology and significance of remodeling in native
coronary arteries. The pathophysiology of vascular remod-
eling is not fully understood. However, available data
suggest that remodeling is initiated by the detection of
signals related to changes in hemodynamic conditions (flow,
wall stretch, shear stress) and humoral factors (cytokines,
vasoactive substances) (2,21,22). Hypothetically, these sig-
nals are relayed within the endothelium (23) and transmit-
ted to adjacent cells, eventually causing the synthesis or
activation of substances that influence cell growth, apopto-
Figure 2. Positive and negative arterial remodeling describes extremes of the remodeling response. Longitudinal sections through vessel segments with
positively and negatively remodeled lesions are shown. EEM 5 external elastic membrane; remodeling ratio (RR) 5 EEM area lesion/EEM area proximal
reference.
Figure 3. Intravascular ultrasound images show tomographic sections of the vessel, including lumen, vessel wall and adventitia. EEM 5 external elastic
membrane.
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sis, migration and the composition of the extracellular
matrix (24). The extracellular matrix, which is the connec-
tive tissue scaffolding of the vessel wall, appears to have a
central role in the remodeling process. A group of enzymes,
the matrix-metalloproteinases, regulate the composition of
the extracellular matrix by selective degradation of its
components and may have an important role in the remod-
eling response (25–28). The respective role of changes in the
media and adventitia in the process of remodeling is not
completely understood. Several investigators have described
a prominent contribution of the adventitia. Other groups
demonstrate early changes in the media. Medial thinning
appears to be an early and important finding in atheroscle-
rotic lesions (3,29–32). The interaction between medial and
adventitial pathology and the intimal atherosclerotic process
deserves further investigation.
Positive remodeling was initially described as a compen-
satory mechanism in early coronary artery disease preventing
luminal loss despite plaque accumulation. However, recent
studies have revealed an association between the direction of
remodeling and clinical presentation (33,34). Smits et al.
(33) performed coronary angioscopy and IVUS in 34
patients before intervention. Lesions were classified by
angioscopic criteria as smooth or complex. Using IVUS the
remodeling response was defined as the ratio of the EEM
area at the lesion and reference site. Stable and unstable
lesions were defined by the clinical presentation. Unstable
lesions were more commonly characterized by positive than
Figure 4. Example of negative remodeling. Intravascular ultrasound images of the proximal reference and lesion site are shown. The remodeling ratio is
0.71. EEM 5 external elastic membrane.
Figure 5. Example of positive remodeling. Intravascular ultrasound images of the proximal reference and lesion site are shown. The remodeling ratio is 1.32.
EEM 5 external elastic membrane.
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negative remodeling (58% vs. 17%), whereas stable lesions
more often showed negative than positive remodeling (50%
vs. 12.5%). Also, angioscopically complex lesions more
often had positive than negative remodeling (57% vs. 14%).
The pathophysiologic mechanisms linking plaque vulner-
ability and remodeling have not been established with
certainty. However, inflammation may represent a common
link. Inflammatory markers such as macrophages and
matrix-metalloproteinases have an established role in the
pathophysiology of plaque rupture (35–37). Recent histo-
logic studies suggest a similar relationship between inflam-
mation and remodeling (28,38). Pasterkamp et al. (38)
describes an association between histologic markers associ-
ated with plaque inflammation and positive arterial remod-
eling in femoral arteries.
It is an attractive hypothesis to describe the direction of
remodeling in relation to the temporal development of
plaques (Figs. 1 and 8). Positive remodeling may be a
characteristic of early, “proliferative” lesions, allowing con-
siderable plaque accumulation despite normal luminal size.
These accumulating plaques, characterized by inflammatory
and proliferative processes, may be particularly “vulnerable”
to rupture leading to acute coronary syndromes (39). The
fibrotic changes associated with negative remodeling of
advanced plaques could lead to a reduced risk of plaque
rupture and, therefore, plaque stabilization.
Plaque stabilization related to changes of lesion compo-
sition and architecture has been examined in animal exper-
iments (40–44), but in only a few clinical studies. A relation
between remodeling and lipid metabolism is suggested by
epidemiologic studies demonstrating that high serum or
plaque-tissue cholesterol levels are associated with positive
remodeling (45). A small IVUS study examined the effect of
three-year treatment with pravastatin on mildly diseased
coronary arteries (46). During follow-up plaque area in-
creased by 41% in the control group but decreased by 7% in
the treatment group. External elastic membrane area in-
creased by 9% in the control group but did not change in the
treatment group. Luminal area decreased by 9% in the
control group but increased by 10% in the treatment group.
These preliminary results suggest that regression of athero-
sclerosis entails dynamic changes of plaque size, plaque
composition and remodeling response of the vessel wall, but
need to be confirmed in further prospective studies.
In summary, the observation of remodeling in native
coronary arteries is important in the assessment of plaque
vulnerability and stabilization. The concept that both arte-
rial expansion and shrinkage can be manifestations of
atherosclerosis is supported by basic research (47) and the
clinical analogy between positive remodeling, abdominal
aortic aneurysms (48–50) and coronary ectasia (51,52).
Remodeling and restenosis after coronary interventions.
In animal models arterial remodeling has been shown to
contribute to restenosis after coronary intervention (53,54).
A direct correlation between chronic constriction of the
EEM area (negative remodeling) and late residual stenosis
was found. These results were confirmed in vivo with IVUS.
Mintz et al. (55) studied 212 native coronary lesions
immediately after percutaneous coronary intervention and at
a follow-up catheterization 5.6 6 3.4 months later. The
ultrasound cross-section with the smallest luminal area at
follow-up was compared with the matching site immedi-
ately after intervention. The EEM area increased from
preintervention to postintervention (18.5 6 6.3 mm2 vs.
20.1 6 6.4 mm2), but decreased subsequently between
postintervention and follow-up to 18.2 6 6.4 mm2. Lumi-
nal area increased from preintervention to postintervention
(1.7 6 0.9 mm2 vs. 6.6 6 2.5 mm2) and then decreased to
4.0 6 3.7 mm2 at follow-up. Plaque area increased signif-
icantly between postintervention and follow-up (p ,
0.0001). A total of 73% of luminal loss between postinter-
vention and follow-up was attributable to a decrease in
EEM area, compared with 23% caused by neointimal area
growth. The change in luminal area correlated more
strongly with the change in EEM area (r 5 0.75, p ,
Figure 6. Static observation of arterial remodeling by comparing lesion and
reference site. This figure shows longitudinal and cross-sectional sections
through the lesion and reference. The external elastic membrane (EEM)
area at the lesion site is larger than that at the reference site, defining
positive remodeling.
Figure 7. Serial observation of arterial remodeling. This figure shows
longitudinal and cross-sectional sections through the same lesion at two
different times. The lesion has progressed, characterized by an increased
plaque and vessel size. The vessel expansion is defined as positive
remodeling. EEM 5 external elastic membrane.
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0.0001) than with the change in plaque area (r 5 0.28, p ,
0.0001).
In contrast, 22% of all lesions demonstrated an increase in
EEM area at follow-up. This group showed a reduction in
the angiographic restenosis rate in comparison with lesions
with a decrease in the EEM area at follow-up (26% vs. 62%,
p , 0.0001). Kimura et al. (56) found a time-dependent
bidirectional remodeling response following percutaneous
coronary intervention with early adaptive enlargement and
late shrinkage of the vessel. In this study, 61 lesions were
examined by serial IVUS before and immediately after
intervention and on several occasions over the next six
months. Matched target sites were compared. External
elastic membrane area increased from 15.45 6 5.3 mm2
before intervention to 17.32 6 5.35 mm2 after intervention
and to 19.37 6 5.33 mm2 at one month, then decreased to
16.33 6 5.54 mm2 at six months. Luminal area increased
from 2.08 6 0.7 mm2 before intervention to 6.81 6
2.24 mm2 after intervention and to 8.22 6 2.79 mm2 at one
month, then decreased to 4.88 6 2.86 mm2 at six months.
Plaque area steadily increased from postintervention ultra-
sound to six months follow-up. Changes in luminal area
correlated more closely with changes in EEM size (r 5
0.72, p 5 0.0001) than with changes in plaque area (r 5
0.34, p 5 0.0008).
In these studies, a significant decrease in EEM area
between postintervention and follow-up was observed. Im-
portantly, EEM area was either unchanged or only slightly
different between preintervention and follow-up. In other
words, vessel size at follow-up might have returned to its
preprocedural baseline. It is important to differentiate be-
tween the passive process of elastic recoil and the active
process of negative remodeling. Interventional procedures
are associated with a mechanical expansion of the vessel
wall. Wall stretch was shown in angiographic and IVUS to
represent up to 43% of immediate luminal gain (57).
Opposing forces defined by the elastic or viscoelastic prop-
erties of the vessel wall lead to elastic recoil. Immediate
recoil is typically defined as the difference between the
diameter of the interventional device and the immediate
postinterventional diameter (58), and has been reported in
several studies to cause a luminal loss between 23% and 46%
shortly after balloon deflation (59,60).
The later changes that occur after this “immediate” period
are often defined as negative remodeling, but controversy
exists regarding the contribution of delayed elastic recoil.
Delayed elastic recoil (the correct biomechanical term is
“creep”) is related to the viscoelastic properties of the vessel
wall (61). Although several studies found no significant
decrease in minimal luminal diameter during the first 24 h
after angioplasty (62–64), other studies describe delayed
vessel shrinkage. Nobuyoshi et al. (65) studied 229 patients
with angiography immediately and 24 h after percutaneous
transluminal coronary angioplasty 12 months later. Stenosis
diameter decreased from 1.91 6 0.53 mm immediately after
coronary angioplasty to 1.43 6 0.67 mm at three months.
Mean stenosis diameter did not change further after three
months.
These studies suggest that arterial shrinkage occurring in
native atherosclerosis may be different from that observed
after intervention. After coronary angioplasty the postinter-
ventional EEM diameter gradually returns to but does not
fall below the preinterventional EEM diameter. On the
other hand, negative remodeling in native vessels is charac-
terized by a decrease of vessel size below baseline. Histologic
studies indicate that negative remodeling of native coronary
Figure 8. Direction of remodeling and temporal development of plaques. Positive remodeling may be a characteristic of early, unstable lesions, allowing
considerable plaque accumulation despite normal luminal size. Negative remodeling and fibrotic changes may be associated with more stable plaques. The
observation of remodeling in relation to clinical presentation may be important in the assessment of plaque vulnerability and stabilization. EEM 5 external
elastic membrane.
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arteries is characterized by fibrosis (40,41), whereas resten-
osis is characterized by proliferation and inflammation
(66–68). The significance of this difference is incompletely
understood, but may indicate a different pathophysiology of
vessel shrinkage in native arteries and after intervention.
Recent IVUS studies have examined the relation between
preinterventional direction of remodeling and procedural
outcome. Pasterkamp et al. (15) compared the immediate
result and mechanism of balloon angioplasty in 121 human
femoral artery lesions with positive and negative remodel-
ing. The absolute luminal gain did not differ significantly
between the remodeling groups, but there were differences
in the mechanism. Stretch of the EEM area was signifi-
cantly larger in the group with wall shrinkage than in the
groups with compensatory enlargement. Subsequent lumi-
nal loss secondary to elastic recoil was not significantly
different between the two groups.
Dangas et al. (69) examined whether the direction of
preinterventional remodeling predicts target lesion revascu-
larization rate (TLR) after nonstent intervention. Preinter-
ventional IVUS images of 777 lesions were analyzed. The
TLR rate was higher in the positive remodeling group than
in the negative/intermediate remodeling group (31.2% vs.
20.2%, p 5 0.007). The remodeling index was strongly
correlated with the probability of TLR (p 5 0.0001). An
important limitation of this study is that lesions with
positive remodeling were treated more often with direc-
tional atherectomy whereas balloon angioplasty alone was
more frequent in the negative remodeling group. Another
study found an association between preinterventional posi-
tive remodeling and creatine kinase elevation after interven-
tion (70), suggesting a possible association between positive
remodeling and distal embolization (71).
The role of remodeling after intravascular radiation ther-
apy has recently been described. Waksman et al. (72) report
results from an animal model showing that irradiated vessels
were significantly larger than controls at follow-up. Using
IVUS, Meerkin et al. (73) report absence of shrinkage in
total coronary EEM area in humans during six-month
follow-up after radiation. Recent reports describe the phe-
nomenon of vessel expansion outside of stents after intra-
coronary irradiation.
Arterial remodeling after coronary artery bypass surgery
and cardiac transplantation. Diffuse vascular remodeling
of vein grafts early after coronary bypass surgery is related to
hemodynamic changes affecting the graft (2). Graft luminal
size and patency are critically dependent on flow, with
suboptimal flow after surgery preventing the adaptive dila-
tion of the graft (74,75). Superimposed on this early diffuse
remodeling response is the later development of focal
atherosclerotic plaques, leading to further changes in EEM
and luminal size.
However, cross-sectional IVUS studies examining the
remodeling response in bypass grafts show contradictory
results. Nishioka et al. (76) examined 43 saphenous vein
grafts (SVGs) with IVUS 8 to 23 years after bypass surgery.
Cross-sectional area of the graft at the lesion and reference
site was not significantly different, but lesion sites were
characterized by significantly smaller lumen and larger
plaque size. Contrary to these findings, other studies report
compensatory enlargement in SVGs. Mendelsohn et al. (77)
examined 24 SVG lesions with IVUS between 10 months
and 16 years after surgery. The EEM area was larger at the
lesion site in comparison with the reference site in 96% of
the lesions. A significant correlation between plaque and
EEM area was observed (r 5 0.83, p , 0.001).
Figure 9. Intravascular ultrasound images of a coronary aneurysm. A positive remodeled and a negative remodeled lesion are compared. Both vessel
expansion and luminal obstruction can be manifestations of coronary artery disease.
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The time interval between bypass surgery and IVUS
examination likely explains some of the contradictory results
in these studies, and data about serial examinations of vein
grafts after surgery are preliminary.
The dynamic changes of transplant vasculopathy after
cardiac transplant are reflected in complex time-dependent
changes of remodeling (78–81). Superimposed is the pro-
gression of preexisting atherosclerotic lesions of the trans-
planted coronary vessels (donor disease) (82). Donor-related
lesions may be a particularly interesting model of plaque
progression/regression because of the significant differences
in the risk factor profile of donor and recipient.
A comparison of the remodeling response in native
atherosclerosis, vein graft disease and transplant vasculopa-
thy shows several similarities, suggesting either a common
pathophysiology (e.g., inflammation) or a common patho-
physiologic response to different triggers.
Conclusions. In 1953, Crawford and Levene (3) wrote:
“Atheromatous plaques do not project into the lumen but lie
in a depression in the media which may bulge outwards. In
this way the triad of atheroma, thrombosis and aneurysm
become linked in one continuous pathological process.”
We have learned that expansion and shrinkage of coro-
nary vessels is an important process in coronary artery
disease (CAD). This process of “arterial remodeling” is
fundamental to the pathophysiology of CAD in native
coronary lesions and after interventional procedures such as
angioplasty.
However, the clinical significance of these complex
changes of vessel and plaque size is incompletely under-
stood. The recent in vivo experience with IVUS has con-
firmed that both arterial expansion and shrinkage can be a
manifestation of coronary atherosclerosis. Positive remod-
eling (arterial expansion) is frequently associated with un-
stable coronary syndromes whereas negative remodeling
(arterial shrinkage) is associated with stable coronary syn-
dromes. These changes of vessel size are clearly related to
atherosclerotic disease progression and regression. There-
fore, the observation of remodeling is important in the
assessment of plaque vulnerability and stabilization.
In analogy to the terminology of cardiomyopathic pro-
cesses, we propose to describe “dilated” and “obstructive”
coronary atherosclerosis as extremes of a continuous patho-
logic process (Fig. 9). A better understanding of the
remodeling response may have important implications in
the diagnosis, prevention and treatment of CAD.
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